UCSF
Oncology
Dr. Adil Daud, MD
Doctor Adil Daud, MD works in the field of Oncology. He graduated from Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Adil Daud is also a published doctor. He has 14 paper published. The most recent paper is: Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors. Doctor Adil Daud, MD is registered with Medicare.
Publications
- Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors.
- Involution of Eruptive Melanocytic Nevi on Combination BRAF and MEK Inhibitor Therapy.
- Combinatorial Approach to Treatment of Melanoma.
- A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF (V600E) mutation-positive metastatic Melanoma.
- The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics.
- Safety and tumor responses with lambrolizumab (anti-PD-1) in Melanoma.
- Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines.
- Removing the Unknown From the Carcinoma of Unknown Primary.
- Combined BRAF and MEK inhibition in Melanoma with BRAF V600 mutations.
- Management of pegylated interferon alpha toxicity in adjuvant therapy of Melanoma.
- Cutting edge in medical management of cutaneous oncology.
- Melanoma.
- Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic Melanoma.
Schools
Government Medical College Nagpur Maharashtra University Of Health Sciences
In University School Of Med
Mem Sloan Kettering Cancer Center
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Indiana University School of Medicine -
Government Medical College Nagpur
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1699706812 | |
| NPPES Provider LastName | DAUD | |
| NPPES Provider FirstName | ADIL | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 214.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 22.0 | |
| Percent Opioid Claims | 10.28 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699706812 |
| Last Name Of The Provider | DAUD |
| First Name Of The Provider | ADIL |
| View All |
Similar Doctors
|
Dr. Jeff S. Russell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregoire Bergier, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth Zuckerman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Rami S. Komrokji, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Alan F. List, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Benjamin Creelan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Martine Extermann, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Karen K. Fields, MD |
|
Dr. Jhanelle Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jingsong Zhang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Damian A. Laber, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Elizabeth M. Sagatys, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Danny Nguyen, MD |